Lilly supports research to determine what a dog’s nose knows about people with diabetes and severe hypoglycemia
30 July 2012 | By Eli Lilly and Company
Data to explore future treatment possibilities for people with type 1 diabetes...
List view / Grid view
News
Afinitor® approved by European Commission to treat patients with the most common form of advanced breast cancer
30 July 2012 | By Novartis
The EC has approved Afinitor®...
Abbott’s HUMIRA® (adalimumab) approved in Europe for treatment of non-radiographic axial spondyloarthritis
30 July 2012 | By Abbott
The European Commission has approved HUMIRA®...
GSK announces acquisition of 79% of Human Genome Sciences shares
30 July 2012 | By GlaxoSmithKline
GSK announced the results of its initial tender offer for all outstanding shares of HGS...
Pooled analysis showed Onglyza® provided improvements in key measures of blood sugar control
30 July 2012 | By Bristol-Myers Squibb
Bristol-Myers Squibb and AstraZeneca announced the results of analyses...
Roche reports second positive study of RoACTEMRA given to patients with rheumatoid arthritis
27 July 2012 | By Roche
Data will be submitted to health authorities globally...
Once-daily dolutegravir is non-inferior to twice-daily raltegravir in treatment-naïve adults with HIV-1
27 July 2012 | By GlaxoSmithKline
Findings support progression towards registration...
pSivida announces ILUVIEN® marketing authorisation in Germany
27 July 2012 | By pSivida Corp.
For the treatment of vision impairment associated with chronic diabetic macular edema...
Luitpold Pharmaceuticals, Inc. receives complete response letter for Injectafer® from the U.S. FDA
26 July 2012 | By Daiichi Sankyo
Luitpold Pharmaceuticals submitted a New Drug Application to the U.S. FDA...
FDA clears Roche’s vitamin D laboratory test
26 July 2012 | By Roche
Fully automated assay for widely available platforms offers labs efficient solution to help assess patient vitamin D levels...
Results announcement for the second quarter 2012
25 July 2012 | By GlaxoSmithKline
GSK delivers Q2 core EPS of 26.4p and dividend of 17p...
Sanofi Pasteur’s dengue vaccine demonstrates proof of efficacy
25 July 2012 | By Sanofi Pasteur
Early data analysis confirms excellent safety profile...
Lundbeck disagrees with the Statement of Objections issued by the European Commission
25 July 2012 | By H. Lundbeck A/S
The European Commission has issued a Statement of Objections to Lundbeck...
Jentadueto® tablets receive approval for the treatment of adults with Type 2 Diabetes in Europe
25 July 2012 | By Boehringer Ingelheim
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) received Marketing Authorisation from the European Commission for Jentadueto® which combines the DPP-4 inhibitor, linagliptin and metformin in a single tablet. 1 Linagliptin/metformin hydrochloride (HCl) will provide a new, single-tablet treatment option, taken twice-daily, for adults with Type 2 Diabetes. 1
Merck collaborators publish study showing potential for eradication of persistent HIV virus in the body
25 July 2012 | By Merck
Merck announced the publication of a study...
